stockrowWarby Parker Inc.
WRBY Healthcare Medical Instruments & Supplies
Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024.
- Revenue
- +10.4%
- EPS
- −20.0%
- Free cash flow
- −30.3%
Quarter to September 2026, against a year earlier
Follow WRBY
Alert me
Warby Parker Inc. (WRBY) Book value per share
Warby Parker Inc.'s book value per share at the end of fiscal 2025 was 3.0×, up 6.12% from 2.8× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 3.2×. Over the past ten years it has ranged from −3.7× (fiscal 2020) to 4.0× (fiscal 2021); the current reading is higher than 86% of that period. Warby Parker Inc. ranks 33rd of 52 Medical Instruments & Supplies companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 3.0× | 6.12% |
| FY2024 | 2.8× | 9.88% |
| FY2023 | 2.6× | 3.09% |
| FY2022 | 2.5× | (37.87%) |
| FY2021 | 4.0× | — |
| FY2020 | −3.7× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 3.2× | 2.26% |
| Jun 2026 | 3.2× | 3.89% |
| Mar 2026 | 3.0× | 1.56% |
| Dec 2025 | 3.0× | (0.28%) |
| 23 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| ICUI ICU Medical, Inc. compare | 87.6× |
| AZTA Azenta, Inc. compare | 33.3× |
| LMAT LeMaitre Vascular, Inc. compare | 18.9× |
| ATRC AtriCure, Inc. compare | 10.9× |
| XRAY DENTSPLY SIRONA Inc. compare | 6.8× |
| STVN Stevanato Group S.p.A. compare | 6.7× |
| KMTS Kestra Medical Technologies, Ltd. compare | 3.8× |
| WRBY Warby Parker Inc. | 3.2× |
| PLSE Pulse Biosciences, Inc compare | 2.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on WRBY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement